Published in Brain, Behavior and Immunity—is the first to suggest that a tumor-driving gene known as AEG-1 actively regulates the inflammation responsible for causing chemotherapy-induced peripheral neuropathy (CIPN), a common ...
May 28, 2025
0
12
Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to aging, can be found in cancerous ...
Apr 23, 2025
0
24
New research from RCSI University of Medicine and Health Sciences has found that white blood cells which 'remember' past inflammatory events are quick to overreact, raising the risk of blood clots.
Mar 10, 2025
0
28
The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and colleagues have discovered a new approach to treating ovarian cancer, ...
Nov 21, 2024
0
44
Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that ...
Jul 3, 2024
0
85
Findings from the largest UK study of patients hospitalized with SARS-CoV-2 infection show that long COVID leads to ongoing inflammation which can be detected in the blood.
Apr 8, 2024
0
221
Planes, trains, boats, automobiles and even feet. During the past decades and centuries, global travel and human migration have made all of us more worldly—from our broadening awareness of the world beyond our birthplaces, ...
Mar 27, 2024
0
51
Prostate cancer's resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being 'pulled into' tumors, according to new research published in Nature.
Oct 17, 2023
0
83
Interleukin (IL)-11 is produced by inflammatory fibroblasts, one of the stromal cells, during acute colitis. Researchers at Toho University Japan found that IL-11 ameliorated acute colitis in mouse models. The IL-11 production ...
Jan 17, 2023
0
56
Patients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer markers of immune cell exhaustion, and distinct changes to immune cell populations were more likely to have longer ...
Aug 30, 2022
0
55
